World

IMF says Sri Lanka's economy recovery continues

Aug 03, 2024

Colombo [Sri Lanka], August 3: Sri Lanka's economic recovery continues with real gross domestic product (GDP) posting three consecutive quarters of expansion, and growth accelerating to 5.3 percent year-on-year in the first quarter of 2024, the International Monetary Fund (IMF) said on Friday.
An IMF mission team led by senior mission chief Peter Breuer visited Sri Lanka from July 25 to Aug. 2 to discuss recent macroeconomic development and progress in implementing economic and financial policies under an economic reform supported by the IMF's Extended Fund Facility (EFF) arrangement, according to the statement.
Breuer, in his statement, said the economic reform program implemented by the Sri Lankan authorities is yielding commendable outcomes.
Inflation remains below the Central Bank of Sri Lanka's 5-percent target and domestic borrowing rates have declined.
Gross international reserves increased by 1.2 billion U.S. dollars during the first half of 2024, reaching 5.6 billion U.S. dollars, and fiscal revenue collections increased during the same period, he said.
In March 2023, the IMF approved a 48-month extended arrangement under the EFF of about 3 billion dollars to support Sri Lanka's economic policies and reforms.
Source: Xinhua

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025